Objective To put forward some suggestions for the development of urban basic medical insurance of Liaoning by comparing the development situations in 14 cities of Liaoning Province.Methods Relevant data of urban basic...Objective To put forward some suggestions for the development of urban basic medical insurance of Liaoning by comparing the development situations in 14 cities of Liaoning Province.Methods Relevant data of urban basic medical insurance from 2008 to 2018 in 14 cities were collected to make a comparative analysis,and the 5 why analysis chart was drawn to investigate the development differences in 14 cities.Results and Conclusion The average growth rate of the number of urban residents covered by urban basic medical insurance varied greatly from 2014 to 2018.The range of average growth rate of urban residents’medical insurance is 19.1%,and the range of average growth rate of urban workers’medical insurance is 9.1%.Funding standards are basically the same.It is suggested each municipal government should attach importance to this issue.They can make full use of information technology to coordinate with various authorities and ensure the smooth development of medical insurance.Besides,they must actively adapt to their conditions to better develop the urban basic medical insurance of Liaoning.展开更多
Pension insurance is a vital component of China's social security system,ensuring the welfare of the general publie.This study centers on the revenue and expenses of City S's urban employee basic pension insur...Pension insurance is a vital component of China's social security system,ensuring the welfare of the general publie.This study centers on the revenue and expenses of City S's urban employee basic pension insurance fund.It introduces and analyzes the fund's accounting status from four key perspectives:fund raising.expenditure,financial statement system,and accounting information disclosure.The research identifes existing problems in City S's accounting system and conducts in-depth research on these issues.Furthermore,an empirical analysis is conducted on the management of the pension insurance fund.Through this empirical study,the paper aims to offer insights and recommendations for promoting stable and healthy development measures for City S'8 urban employee basic pension insurance fund.展开更多
Reimbursement policy for outpatient chronic diseases is an important part of the basic medical insurance scheme in China. The reimbursement policy for outpatient chronic diseases in basic medical insurance for urban r...Reimbursement policy for outpatient chronic diseases is an important part of the basic medical insurance scheme in China. The reimbursement policy for outpatient chronic diseases in basic medical insurance for urban residents of provincial capitals in China were analyzed from the perspectives of disease types, benefits package, qualification and health service access. Proposals to improve policy design, establish standardized disease inclusion criteria and set reasonable benefits package, strengthen management and complete supporting policy, strengthen policy coordination were put forward according the existing problems such as fragmented policy, great difference in disease types and benefit package, supervision difficulty, incomplete policy framework and lack of policy coordination.展开更多
Background Trastuzumab,a monoclonal antibody for breast cancer,faces global accessibility challenges,primarily due to high costs.This study examines how changes in medical insurance policies and price adjustments infl...Background Trastuzumab,a monoclonal antibody for breast cancer,faces global accessibility challenges,primarily due to high costs.This study examines how changes in medical insurance policies and price adjustments influence Trastuzumab utilization in China,focusing on implementation challenges and their impact on drug accessibility and affordability.Methods This retrospective study investigated Trastuzumab utilization among HER2-positive breast cancer patients at a tertiary hospital from May 2013 to December 2022 in JX,a prefecture-level city in eastern China.Patients were stratified based on their CerbB2 indicator,because those with a 2+CerbB2 status require further FISH testing to con-firm Trastuzumab eligibility.We analyzed the utilization rates of both FISH test and Trastuzumab using logistic regres-sions,identifying factors that influence their usage.Results 766 patients were included.The utilization rate of Trastuzumab among patients with CerbB23+rose from 40.40 to 77.94%in September 2017 following the expansion of insurance coverage,and further increased to 90.41%after a price reduction in 2020.The FISH test was not covered by health insurance,and it was not avail-able in the local hospital until Trastuzumab became available in JX city.For patients with CerbB22+,the proportion undergoing the FISH test increased dramatically from 8.89 to 82.08%after the price reduction in 2020.The mere inclu-sion into basic medical insurance,regardless of insurance types,significantly increased the utilization of Trastuzumab and the FISH test.However,rural patients in JX city are still facing financial burdens with Trastuzumab’s out-of-pocket cost accounting for 62.9%of their annual disposable income in 2020.Conclusions Our findings indicate that insurance coverage and price reduction significantly increased Trastu-zumab utilization.However,failure to improve the accessibility of the FISH test can pose challenges in enhancing the uptake of Trastuzumab among eligible patients.With the expiration of Trastuzumab’s patent and the development of affordable biosimilars,there are now greater opportunities to enhance treatment access globally.These insights can inform policy makers of implementation guidance about providing financial support for breast cancer patients in other LMICs.展开更多
文摘Objective To put forward some suggestions for the development of urban basic medical insurance of Liaoning by comparing the development situations in 14 cities of Liaoning Province.Methods Relevant data of urban basic medical insurance from 2008 to 2018 in 14 cities were collected to make a comparative analysis,and the 5 why analysis chart was drawn to investigate the development differences in 14 cities.Results and Conclusion The average growth rate of the number of urban residents covered by urban basic medical insurance varied greatly from 2014 to 2018.The range of average growth rate of urban residents’medical insurance is 19.1%,and the range of average growth rate of urban workers’medical insurance is 9.1%.Funding standards are basically the same.It is suggested each municipal government should attach importance to this issue.They can make full use of information technology to coordinate with various authorities and ensure the smooth development of medical insurance.Besides,they must actively adapt to their conditions to better develop the urban basic medical insurance of Liaoning.
文摘Pension insurance is a vital component of China's social security system,ensuring the welfare of the general publie.This study centers on the revenue and expenses of City S's urban employee basic pension insurance fund.It introduces and analyzes the fund's accounting status from four key perspectives:fund raising.expenditure,financial statement system,and accounting information disclosure.The research identifes existing problems in City S's accounting system and conducts in-depth research on these issues.Furthermore,an empirical analysis is conducted on the management of the pension insurance fund.Through this empirical study,the paper aims to offer insights and recommendations for promoting stable and healthy development measures for City S'8 urban employee basic pension insurance fund.
文摘Reimbursement policy for outpatient chronic diseases is an important part of the basic medical insurance scheme in China. The reimbursement policy for outpatient chronic diseases in basic medical insurance for urban residents of provincial capitals in China were analyzed from the perspectives of disease types, benefits package, qualification and health service access. Proposals to improve policy design, establish standardized disease inclusion criteria and set reasonable benefits package, strengthen management and complete supporting policy, strengthen policy coordination were put forward according the existing problems such as fragmented policy, great difference in disease types and benefit package, supervision difficulty, incomplete policy framework and lack of policy coordination.
基金The research results of this article(or publication)are sponsored by the Kunshan Municipal Government(23KKSGR015)research funding.
文摘Background Trastuzumab,a monoclonal antibody for breast cancer,faces global accessibility challenges,primarily due to high costs.This study examines how changes in medical insurance policies and price adjustments influence Trastuzumab utilization in China,focusing on implementation challenges and their impact on drug accessibility and affordability.Methods This retrospective study investigated Trastuzumab utilization among HER2-positive breast cancer patients at a tertiary hospital from May 2013 to December 2022 in JX,a prefecture-level city in eastern China.Patients were stratified based on their CerbB2 indicator,because those with a 2+CerbB2 status require further FISH testing to con-firm Trastuzumab eligibility.We analyzed the utilization rates of both FISH test and Trastuzumab using logistic regres-sions,identifying factors that influence their usage.Results 766 patients were included.The utilization rate of Trastuzumab among patients with CerbB23+rose from 40.40 to 77.94%in September 2017 following the expansion of insurance coverage,and further increased to 90.41%after a price reduction in 2020.The FISH test was not covered by health insurance,and it was not avail-able in the local hospital until Trastuzumab became available in JX city.For patients with CerbB22+,the proportion undergoing the FISH test increased dramatically from 8.89 to 82.08%after the price reduction in 2020.The mere inclu-sion into basic medical insurance,regardless of insurance types,significantly increased the utilization of Trastuzumab and the FISH test.However,rural patients in JX city are still facing financial burdens with Trastuzumab’s out-of-pocket cost accounting for 62.9%of their annual disposable income in 2020.Conclusions Our findings indicate that insurance coverage and price reduction significantly increased Trastu-zumab utilization.However,failure to improve the accessibility of the FISH test can pose challenges in enhancing the uptake of Trastuzumab among eligible patients.With the expiration of Trastuzumab’s patent and the development of affordable biosimilars,there are now greater opportunities to enhance treatment access globally.These insights can inform policy makers of implementation guidance about providing financial support for breast cancer patients in other LMICs.
